IL1A and melanoma: We show that cross talk between melanoma cells, macrophages, and fibroblasts initiates an IL-1 signaling cascade that generates a CXCR2-stimulating secretome, which ultimately leads to enhanced melanoma cell survival in the presence of MAPK signaling inhibition, via BCL2 up-regulation (Fig. 10 F).